SeqCure Immunology AB
559094-7031ActiveDeveloping personalized, non-genetically engineered cell therapy for advanced cancer.
Biotechnology Startupseqcureimmunology.com
Yleiskatsaus
- 1–4
- Työntekijät
- 1–2.5milj SEK
- Liikevaihto
- 2016
- Perustettu
Kuvaus
SeqCure Immunology is a Stockholm-based biotechnology startup dedicated to advancing cancer immunotherapies. The company is developing SeqCureNEO, a novel, curative, personalized cell therapy designed for treating advanced-stage cancers. This therapy is manufactured using the patient's own isolated...
Tunnisteet
B2BPharmaceuticalsTechnology
Avainsanat
BiotechCancer TreatmentCell Therapy